MedTrace Logo

Effectiveness of Two Hyaluronic Acids in Osteoarthritis of the Knee

NCT01543737 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 290

Last updated 2016-02-12

No results posted yet for this study

Summary

The purpose of this study is to assess whether a single injection hyaluronic acid (HA) product is not inferior to a 3 injection HA product at 24 weeks (6 months), in terms of effectiveness in reducing pain when walking in patients suffering from symptomatic tibiofemoral osteoarthritis of the knee.

Conditions

Interventions

DEVICE

3ml hyaluronic acid (DUROLANE)

DUROLANE Hyaluronic acid 20mg/ml

DEVICE

2ml hyaluronic acid, (HYALGAN)

HYALGAN Hyaluronic acid 10mg/ml

Sponsors & Collaborators

  • Bioventus LLC

    lead INDUSTRY

Principal Investigators

  • Thierry Conrozier, MD · Lyon University Hospital (HCL)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2014-02-28
Completion
2014-02-28

Countries

  • France
  • Monaco

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01543737 on ClinicalTrials.gov